Cargando…

Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial

INTRODUCTION: Keratosis pilaris (KP) is a disfiguring disease and is resistant to treatment. Several treatment methods are available, but the efficacy is limited. This prospective, rater-blinded, split-body comparative study investigated the efficacy and safety of long-pulsed 755-nm alexandrite lase...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Man, Bai, Yue, Duan, Zhixuan, Yuan, Ruofei, Liu, Xiaoduo, Liu, Yi, Liang, Xuelei, Wu, Haixuan, Zhuo, Fenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357583/
https://www.ncbi.nlm.nih.gov/pubmed/35838863
http://dx.doi.org/10.1007/s13555-022-00771-5
_version_ 1784763741640851456
author Li, Man
Bai, Yue
Duan, Zhixuan
Yuan, Ruofei
Liu, Xiaoduo
Liu, Yi
Liang, Xuelei
Wu, Haixuan
Zhuo, Fenglin
author_facet Li, Man
Bai, Yue
Duan, Zhixuan
Yuan, Ruofei
Liu, Xiaoduo
Liu, Yi
Liang, Xuelei
Wu, Haixuan
Zhuo, Fenglin
author_sort Li, Man
collection PubMed
description INTRODUCTION: Keratosis pilaris (KP) is a disfiguring disease and is resistant to treatment. Several treatment methods are available, but the efficacy is limited. This prospective, rater-blinded, split-body comparative study investigated the efficacy and safety of long-pulsed 755-nm alexandrite laser in the treatment of KP. METHODS: Twenty-two patients with KP of bilateral arms were enrolled in this study. All participants were randomized and treated with a long-pulsed 755-nm alexandrite laser on the left or right arm in four sessions held 3 weeks apart. The unified moisturizing lotion was applied on both left and right arms once a day. Physicians’ assessment scores and patients’ self-assessment scores were recorded, and skin imaging changes in dermoscopy, high-frequency ultrasound, and skin biopsy were obtained at baseline and 4 weeks after the fourth treatment. RESULTS: Of the 21 patients who completed the study, 15 were women and 6 were men. At 4 weeks after the fourth treatment, the laser side showed significantly lower total (2.0 versus 4.5), roughness (1.0 versus 2.0), and redness (1.0 versus 2.0) scores according to physicians’ assessment (all P < 0.05). Furthermore, the laser side showed significantly lower total (2.0 versus 4.0), roughness (1.0 versus 2.0), and redness scores (1.0 versus 2.0) according to the patients’ self-assessment (all P < 0.05). The proportions of patients who achieved dermoscopically and ultrasonographically showed excellent improvements in follicular plugs (57.1% versus 14.3%), perifollicular erythema (52.4% versus 9.5%), perifollicular hyperpigmentation (47.6% versus 14.3%), and the number of epidermal bulges (57.1% versus 19.1%) in the laser side was significantly higher than those who achieved such improvements in the control side (all P < 0.05). Histopathology showed that the follicular plugs and inflammatory cell infiltration were improved at the final visit. Three patients exhibited reversible postinflammatory hyperpigmentation. CONCLUSION: Long-pulsed 755-nm alexandrite laser treatment is effective and safe in treating both skin roughness and redness in KP. Trial Registration Number: ChiCTR2100054489.
format Online
Article
Text
id pubmed-9357583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-93575832022-08-10 Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial Li, Man Bai, Yue Duan, Zhixuan Yuan, Ruofei Liu, Xiaoduo Liu, Yi Liang, Xuelei Wu, Haixuan Zhuo, Fenglin Dermatol Ther (Heidelb) Original Research INTRODUCTION: Keratosis pilaris (KP) is a disfiguring disease and is resistant to treatment. Several treatment methods are available, but the efficacy is limited. This prospective, rater-blinded, split-body comparative study investigated the efficacy and safety of long-pulsed 755-nm alexandrite laser in the treatment of KP. METHODS: Twenty-two patients with KP of bilateral arms were enrolled in this study. All participants were randomized and treated with a long-pulsed 755-nm alexandrite laser on the left or right arm in four sessions held 3 weeks apart. The unified moisturizing lotion was applied on both left and right arms once a day. Physicians’ assessment scores and patients’ self-assessment scores were recorded, and skin imaging changes in dermoscopy, high-frequency ultrasound, and skin biopsy were obtained at baseline and 4 weeks after the fourth treatment. RESULTS: Of the 21 patients who completed the study, 15 were women and 6 were men. At 4 weeks after the fourth treatment, the laser side showed significantly lower total (2.0 versus 4.5), roughness (1.0 versus 2.0), and redness (1.0 versus 2.0) scores according to physicians’ assessment (all P < 0.05). Furthermore, the laser side showed significantly lower total (2.0 versus 4.0), roughness (1.0 versus 2.0), and redness scores (1.0 versus 2.0) according to the patients’ self-assessment (all P < 0.05). The proportions of patients who achieved dermoscopically and ultrasonographically showed excellent improvements in follicular plugs (57.1% versus 14.3%), perifollicular erythema (52.4% versus 9.5%), perifollicular hyperpigmentation (47.6% versus 14.3%), and the number of epidermal bulges (57.1% versus 19.1%) in the laser side was significantly higher than those who achieved such improvements in the control side (all P < 0.05). Histopathology showed that the follicular plugs and inflammatory cell infiltration were improved at the final visit. Three patients exhibited reversible postinflammatory hyperpigmentation. CONCLUSION: Long-pulsed 755-nm alexandrite laser treatment is effective and safe in treating both skin roughness and redness in KP. Trial Registration Number: ChiCTR2100054489. Springer Healthcare 2022-07-15 /pmc/articles/PMC9357583/ /pubmed/35838863 http://dx.doi.org/10.1007/s13555-022-00771-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Li, Man
Bai, Yue
Duan, Zhixuan
Yuan, Ruofei
Liu, Xiaoduo
Liu, Yi
Liang, Xuelei
Wu, Haixuan
Zhuo, Fenglin
Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title_full Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title_fullStr Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title_full_unstemmed Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title_short Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial
title_sort efficacy and safety of long-pulsed 755-nm alexandrite laser for keratosis pilaris: a split-body randomized clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357583/
https://www.ncbi.nlm.nih.gov/pubmed/35838863
http://dx.doi.org/10.1007/s13555-022-00771-5
work_keys_str_mv AT liman efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT baiyue efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT duanzhixuan efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT yuanruofei efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT liuxiaoduo efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT liuyi efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT liangxuelei efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT wuhaixuan efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial
AT zhuofenglin efficacyandsafetyoflongpulsed755nmalexandritelaserforkeratosispilarisasplitbodyrandomizedclinicaltrial